potassium voltage-gated channel, subfamily H (eag-related), member 2 |
HALOPERIDOL |
Potassium Channel HERG |
99% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
HALOPERIDOL |
Potassium Channel HERG |
99% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
HALOPERIDOL |
Potassium Channel HERG |
99% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
HALOPERIDOL |
Potassium Channel HERG |
99% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
HALOPERIDOL |
Potassium Channel HERG |
99% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
HALOPERIDOL |
Potassium Channel HERG |
99% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
BW-723C86 |
Serotonin 5-HT2C |
99% |
.2043uM |
.107uM |
View
|
opioid receptor, sigma 1 |
SULOCTIDIL |
Sigma1 |
99% |
.1172uM |
.0493uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
SULOCTIDIL |
Calcium Channel Type L, Benzothiazepine |
99% |
.1712uM |
.1522uM |
View
|
Cytochrom P450-1A2 monooxygenase |
HEXACHLOROPHENE |
CYP450-1A2 Inhibition |
99% |
1.3133uM |
NoneNone |
View
|
opioid receptor, sigma 1 |
FLUNARIZINE |
Sigma1 |
99% |
.025uM |
.01uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
PROPAFENONE |
Serotonin 5-HT2C |
99% |
.384uM |
.201uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
DESLORATADINE |
Serotonin 5-HT2B |
99% |
.043uM |
.028uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
THIORIDAZINE |
Serotonin 5-HT2A |
99% |
.004366uM |
.001247uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
DOMPERIDONE |
Serotonin 5-HT2A |
99% |
.037uM |
.011uM |
View
|
cholinergic receptor, muscarinic 5 |
DESLORATADINE |
Muscarinic M5 |
99% |
.292uM |
.21uM |
View
|
cholinergic receptor, muscarinic 3 |
THIORIDAZINE |
Muscarinic M3 |
99% |
.09uM |
.019uM |
View
|
cholinergic receptor, muscarinic 4 |
THIORIDAZINE |
Muscarinic M4 |
99% |
.08uM |
.011uM |
View
|
cholinergic receptor, muscarinic 2 |
THIORIDAZINE |
Muscarinic M2 |
99% |
.106uM |
.038uM |
View
|
cholinergic receptor, muscarinic 2 |
METHSCOPOLAMINE BROMIDE |
Muscarinic M2 |
99% |
.000422uM |
.00015uM |
View
|
cholinergic receptor, muscarinic 1 |
METHSCOPOLAMINE BROMIDE |
Muscarinic M1 |
99% |
.001334uM |
.000321uM |
View
|
histamine receptor H 1 |
FLUNARIZINE |
Histamine H1, Central |
99% |
.158uM |
.018uM |
View
|
prostaglandin-endoperoxide synthase 1 |
BROMFENAC |
Cyclooxygenase COX-1 |
99% |
.008481uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
BROMFENAC |
Cyclooxygenase COX-1 |
99% |
.008481uM |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
DIPHENIDOL |
CYP450-2D6 Inhibition |
99% |
.3263uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide |
PROSCILLARIDIN |
ATPase, Na+/K+ |
99% |
.088uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
PROSCILLARIDIN |
ATPase, Na+/K+ |
99% |
.088uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
PROSCILLARIDIN |
ATPase, Na+/K+ |
99% |
.088uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
PROSCILLARIDIN |
ATPase, Na+/K+ |
99% |
.088uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
PROSCILLARIDIN |
ATPase, Na+/K+ |
99% |
.088uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 3 polypeptide |
PROSCILLARIDIN |
ATPase, Na+/K+ |
99% |
.088uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
PROSCILLARIDIN |
ATPase, Na+/K+ |
99% |
.088uM |
NoneNone |
View
|
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
PROSCILLARIDIN |
ATPase, Na+/K+ |
99% |
.088uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
PIPERILATE ETHOBROMIDE |
Muscarinic M5 |
99% |
.107uM |
.077uM |
View
|
cholinergic receptor, muscarinic 3 |
PIPERILATE ETHOBROMIDE |
Muscarinic M3 |
99% |
.157uM |
.033uM |
View
|
cholinergic receptor, muscarinic 4 |
PIPERILATE ETHOBROMIDE |
Muscarinic M4 |
99% |
.062uM |
.008584uM |
View
|
adrenergic receptor, alpha 2a |
BITHIONOL |
Adrenergic alpha2A |
99% |
3.824uM |
1.434uM |
View
|
adrenergic receptor, alpha 2a |
ALPHA-ERGOCRYPTINE |
Adrenergic alpha2A |
99% |
.007946uM |
.00298uM |
View
|
progesterone receptor |
ETHISTERONE |
Progesterone |
99% |
.059uM |
.00775uM |
View
|
progesterone receptor |
ETHISTERONE |
Progesterone |
99% |
.059uM |
.00775uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
METHYLERGONOVINE |
Serotonin 5-HT1A |
99% |
.00407uM |
.002326uM |
View
|
cholinergic receptor, muscarinic 4 |
BENZTROPINE |
Muscarinic M4 |
99% |
.002385uM |
.000333uM |
View
|
adrenergic receptor, alpha 2b |
PIPAMAZINE |
Adrenergic alpha2C |
98% |
.045uM |
.006468uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
PIPAMAZINE |
Adrenergic alpha2C |
98% |
.045uM |
.006468uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
NIMODIPINE |
Calcium Channel Type L, Dihydropyridine |
98% |
.000242uM |
.000156uM |
View
|
acetylcholinesterase (YT blood group) |
NEOSTIGMINE BROMIDE |
Acetylcholinesterase |
98% |
.2uM |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
NEOSTIGMINE BROMIDE |
Acetylcholinesterase |
98% |
.2uM |
NoneNone |
View
|
acetylcholinesterase |
NEOSTIGMINE BROMIDE |
Acetylcholinesterase |
98% |
.2uM |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
OXICONAZOLE |
Adrenergic alpha2C |
98% |
4.1645uM |
.6051uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
OXICONAZOLE |
Adrenergic alpha2C |
98% |
4.1645uM |
.6051uM |
View
|
dopamine receptor D3 |
OXYBUTYNIN |
Dopamine D3 |
98% |
.4288uM |
.1456uM |
View
|
cholinergic receptor, muscarinic 2 |
ORPHENADRINE |
Muscarinic M2 |
98% |
.376uM |
.134uM |
View
|
dopamine receptor D3 |
LEVOSULPIRIDE |
Dopamine D3 |
98% |
.123uM |
.042uM |
View
|
adrenergic receptor, alpha 1a |
OXYMETAZOLINE |
Adrenergic alpha1A |
98% |
.038uM |
.016uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
PROCHLORPERAZINE |
Adrenergic alpha1D |
98% |
.034uM |
.016uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CYPROHEPTADINE |
Calcium Channel Type L, Benzothiazepine |
98% |
1.925uM |
1.711uM |
View
|
carbonic anhydrase 5a, mitochondrial |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase 3 |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase 2 |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase 4 |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase XI |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase IX |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase VIII |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase VII |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase VA, mitochondrial |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase IV |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase III, muscle specific |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase I |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase XIV |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase VB, mitochondrial |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase XII |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase VI |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
carbonic anhydrase II |
PIOGLITAZONE |
Carbonic Anhydrase |
98% |
.114uM |
NoneNone |
View
|
nuclear receptor subfamily 3, group C, member 1 |
FLUOROMETHOLONE |
Glucocorticoid |
98% |
.003471uM |
.001578uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
CYPROHEPTADINE |
Serotonin 5-HT2C |
98% |
.00244uM |
.001278uM |
View
|
dopamine receptor D1A |
CYPROHEPTADINE |
Dopamine D1 |
98% |
.158uM |
.079uM |
View
|
cholinergic receptor, muscarinic 5 |
CYPROHEPTADINE |
Muscarinic M5 |
98% |
.003835uM |
.002755uM |
View
|
dopamine receptor 2 |
METOCLOPRAMIDE |
Dopamine D2L |
98% |
.127uM |
.042uM |
View
|
cholinergic receptor, muscarinic 3 |
HOMATROPINE HYDROBROMIDE |
Muscarinic M3 |
98% |
.076uM |
.016uM |
View
|
cholinergic receptor, muscarinic 5 |
HOMATROPINE HYDROBROMIDE |
Muscarinic M5 |
98% |
.055uM |
.039uM |
View
|
dopamine receptor 2 |
PIPAMAZINE |
Dopamine D2L |
98% |
.00405uM |
.00135uM |
View
|
adenosine A1 receptor |
ECONAZOLE |
Adenosine A1 |
98% |
16.924uM |
9.872uM |
View
|
cholinergic receptor, muscarinic 3 |
MICONAZOLE |
Muscarinic M3 |
98% |
3.154uM |
.668uM |
View
|
adenosine A1 receptor |
MICONAZOLE |
Adenosine A1 |
98% |
12.519uM |
7.303uM |
View
|
mu-opioid receptor MOR |
MICONAZOLE |
Opiate mu |
98% |
6.059uM |
2.46uM |
View
|
cholinergic receptor, muscarinic 1 |
DEXCHLORPHENIRAMINE |
Muscarinic M1 |
98% |
1.383uM |
.333uM |
View
|
adrenergic receptor, alpha 2a |
ERGOCORNINE |
Adrenergic alpha2A |
98% |
.006296uM |
.002361uM |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
MEVASTATIN |
HMG-CoA Reductase |
98% |
.119uM |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
HEXACHLOROPHENE |
CYP450-2C19 Inhibition |
98% |
1.2265uM |
NoneNone |
View
|
acetylcholinesterase (YT blood group) |
HEXACHLOROPHENE |
Acetylcholinesterase |
98% |
3.0149uM |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
CLOTRIMAZOLE |
Sodium Channel, Site 2 |
98% |
6.771uM |
6.071uM |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
HEXACHLOROPHENE |
Acetylcholinesterase |
98% |
3.0149uM |
NoneNone |
View
|
acetylcholinesterase |
HEXACHLOROPHENE |
Acetylcholinesterase |
98% |
3.0149uM |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
METHAPYRILENE |
Serotonin Transporter |
98% |
.2uM |
.106uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
METHAPYRILENE |
Serotonin 5-HT2C |
98% |
.744uM |
.39uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
TERFENADINE |
Serotonin 5-HT2A |
98% |
.255uM |
.073uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
CYCLIZINE |
Serotonin 5-HT2A |
98% |
.225uM |
.064uM |
View
|
lymphocyte protein tyrosine kinase (mapped) |
IODOQUINOL |
Protein Tyrosine Kinase, Lck |
98% |
2.461uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
THIORIDAZINE |
Muscarinic M5 |
98% |
.009246uM |
.006643uM |
View
|
cholinergic receptor, muscarinic 5 |
VALETHAMATE BROMIDE |
Muscarinic M5 |
98% |
.034uM |
.024uM |
View
|
cholinergic receptor, muscarinic 2 |
DESLORATADINE |
Muscarinic M2 |
98% |
.107uM |
.038uM |
View
|
cholinergic receptor, muscarinic 1 |
DIMENHYDRINATE |
Muscarinic M1 |
98% |
.451uM |
.109uM |
View
|
cysteinyl leukotriene receptor 1 |
ZAFIRLUKAST |
Leukotriene D4 |
98% |
.001731uM |
.000865uM |
View
|
cysteinyl leukotriene receptor 1 |
ZAFIRLUKAST |
Leukotriene D4 |
98% |
.001731uM |
.000865uM |
View
|
histamine receptor H 1 |
THIORIDAZINE |
Histamine H1, Central |
98% |
.072uM |
.008412uM |
View
|
histamine receptor H 1 |
CINNARIZINE |
Histamine H1, Central |
98% |
.074uM |
.008622uM |
View
|
dopamine receptor 2 |
DOMPERIDONE |
Dopamine D2L |
98% |
.002647uM |
.000882uM |
View
|
dopamine receptor D1A |
THIORIDAZINE |
Dopamine D1 |
98% |
.194uM |
.097uM |
View
|
Cytochrom P450-2D6 monooxygenase |
BOPINDOLOL |
CYP450-2D6 Inhibition |
98% |
5.4764uM |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
PERGOLIDE |
CYP450-2D6 Inhibition |
98% |
.2uM |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
IDEBENONE |
CYP450-2C19 Inhibition |
98% |
.8uM |
NoneNone |
View
|
mitogen activated protein kinase 14 |
BITHIONOL |
Protein Serine/Threonine Kinase, p38alpha |
98% |
.318uM |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
BITHIONOL |
Protein Serine/Threonine Kinase, p38alpha |
98% |
.318uM |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
BERBERINE CHLORIDE |
Adrenergic alpha2B |
98% |
.601uM |
.274uM |
View
|
cholinergic receptor, muscarinic 4 |
DIPHENIDOL |
Muscarinic M4 |
98% |
.271uM |
.038uM |
View
|
androgen receptor |
MEDROXYPROGESTERONE ACETATE |
Testosterone |
98% |
.007259uM |
.004839uM |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
BITHIONOL |
Protein Tyrosine Kinase, HER2 Receptor |
98% |
2.147uM |
NoneNone |
View
|
A3 adenosine receptor |
BITHIONOL |
Adenosine A3 |
98% |
.829uM |
.468uM |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
BITHIONOL |
Protein Tyrosine Kinase, HER2 Receptor |
98% |
2.147uM |
NoneNone |
View
|
nuclear receptor subfamily 3, group C, member 1 |
MEDROXYPROGESTERONE ACETATE |
Glucocorticoid |
98% |
.019uM |
.008637uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
ALPHA-ERGOCRYPTINE |
Serotonin 5-HT2C |
98% |
.147uM |
.077uM |
View
|
dopamine receptor D3 |
METHYLERGONOVINE |
Dopamine D3 |
98% |
.167uM |
.057uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
METHYLERGONOVINE |
Serotonin 5-HT2C |
98% |
.013uM |
.006558uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
METHYLERGONOVINE |
Serotonin 5-HT2A |
98% |
.002547uM |
.000728uM |
View
|
adrenergic receptor, alpha 1a |
DOBUTAMINE |
Adrenergic alpha1A |
98% |
.11uM |
.045uM |
View
|
cholinergic receptor, muscarinic 5 |
MAPROTILINE |
Muscarinic M5 |
98% |
.16uM |
.115uM |
View
|
adrenergic receptor, beta 1 |
(S)-(-)-PINDOLOL |
Adrenergic beta1 |
98% |
.000752uM |
.000434uM |
View
|
adrenergic, beta-1-, receptor |
(S)-(-)-PINDOLOL |
Adrenergic beta1 |
98% |
.000752uM |
.000434uM |
View
|
adrenergic receptor, alpha 1b |
LISURIDE |
Adrenergic alpha1B |
98% |
.121uM |
.067uM |
View
|
dopamine receptor 2 |
ERGOTAMINE |
Dopamine D2L |
98% |
.0043uM |
.001433uM |
View
|
adrenergic receptor, alpha 1a |
DOMPERIDONE |
Adrenergic alpha1A |
98% |
.285uM |
.116uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
ERGOTAMINE |
Serotonin 5-HT1A |
98% |
.000774uM |
.000443uM |
View
|
adrenergic receptor, alpha 2b |
ERGOTAMINE |
Adrenergic alpha2C |
98% |
.012uM |
.001809uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
ERGOTAMINE |
Adrenergic alpha2C |
98% |
.012uM |
.001809uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
PYRILAMINE |
Serotonin Transporter |
98% |
.047uM |
.025uM |
View
|
adrenergic receptor, alpha 2a |
PROMAZINE |
Adrenergic alpha2A |
98% |
.337uM |
.126uM |
View
|
cholinergic receptor, muscarinic 5 |
PROMAZINE |
Muscarinic M5 |
98% |
.064uM |
.046uM |
View
|
sodium channel, voltage-gated, type X, alpha |
CLOTRIMAZOLE |
Sodium Channel, Site 2 |
98% |
6.771uM |
6.071uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
PROMAZINE |
Serotonin Transporter |
98% |
.086uM |
.046uM |
View
|
adrenergic receptor, alpha 2b |
PROMAZINE |
Adrenergic alpha2C |
98% |
.253uM |
.037uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
PROMAZINE |
Adrenergic alpha2C |
98% |
.253uM |
.037uM |
View
|
cholinergic receptor, muscarinic 4 |
PROMAZINE |
Muscarinic M4 |
98% |
.299uM |
.042uM |
View
|
cholinergic receptor, muscarinic 4 |
PAROXETINE |
Muscarinic M4 |
98% |
.244uM |
.034uM |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
ZOPICLONE |
GABAA, Benzodiazepine, Central |
98% |
.125uM |
.102uM |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
ZOPICLONE |
GABAA, Benzodiazepine, Central |
98% |
.125uM |
.102uM |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
ZOPICLONE |
GABAA, Benzodiazepine, Central |
98% |
.125uM |
.102uM |
View
|
gamma-aminobutyric acid A receptor, delta |
ZOPICLONE |
GABAA, Benzodiazepine, Central |
98% |
.125uM |
.102uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
ZOPICLONE |
GABAA, Benzodiazepine, Central |
98% |
.125uM |
.102uM |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
OXICONAZOLE |
Acetylcholinesterase |
97% |
4.6465uM |
NoneNone |
View
|
acetylcholinesterase |
OXICONAZOLE |
Acetylcholinesterase |
97% |
4.6465uM |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
EBASTINE |
Protein Tyrosine Kinase, Fyn |
97% |
.8101uM |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
EBASTINE |
Adrenergic alpha2B |
97% |
.7389uM |
.3373uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
EBASTINE |
Serotonin 5-HT2B |
97% |
.3126uM |
.1989uM |
View
|